|
|||||
|
|
Effectiveness and safety of rivaroxaban vs warfarin in people with non‐valvular atrial fibrillation and diabetes: an administrative claims database analysis |
|
| Authors: | C. I. Coleman T. J. Bunz D. Eriksson A.‐K. Meinecke N. A. Sood |
| Affiliation: | 1. University of Connecticut School of Pharmacy, Storrs, CT;2. Hartford Hospital, Hartford, CT;3. New England Health Analytics, LLC, Granby, CT, USA;4. Bayer AG, Berlin, Germany;5. Department of Cardiac Electrophysiology, Southcoast Health System, Fall River, MA, USA |
| Abstract: | |
| Keywords: | |